Literature DB >> 760352

Normalization of the insulin sensitivity and the cellular insulin binding during treatment of obese diabetics for one year.

H Beck-Nielsen, O Pedersen, H O Lindskov.   

Abstract

The relative importance of the insulin resistance, the decreased cellular insulin binding and the relative insulin deficiency in the pathogenesis of diabetes mellitus in obese subjects has been studied. Ten obese diabetics were studied before and during treatment for 1 year with a 1200-1500 kcal's diet. No change was found in the insulin response to iv injection of glucose during treatment (P greater than 0.1), whereas the insulin sensitivity was normalized after 1 year (P less than 0.01). In parallel to the clinical normalization and the improvement of the insulin sensitivity the insulin binding to monocytes was normalized (P less than 0.01). We conclude that both the insulin resistance and the relative insulin deficiency are of decisive importance in the pathogenesis of diabetes mellitus of the obese. The insulin receptor defect seems to be one of the major factors responsible for the insulin resistance.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 760352     DOI: 10.1530/acta.0.0900103

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN: 0001-5598


  6 in total

Review 1.  Advances in diabetes for the millennium: understanding insulin resistance.

Authors:  John E Gerich; George Dailey
Journal:  MedGenMed       Date:  2004-08-26

2.  Insulin receptors and insulin sensitivity in normo and hyperinsulinemic obese patients.

Authors:  A Carducci Artenisio; F Ragonese; F Forte; G Saitta; G Perrone; G Lettina; R Campisi; F Consolo
Journal:  J Endocrinol Invest       Date:  1985-06       Impact factor: 4.256

3.  Trial of sulfonylurea in combination with insulin in the therapy of diabetes type I and II. Evidence against a primary extrapancreatic receptor effect.

Authors:  W P Bieger; R Dlugosch; A Rettenmeier; H D Holler; H Bert; W Schwarz; W Fiehn; J Merkt; H Weicker
Journal:  Klin Wochenschr       Date:  1984-07-02

4.  The effect of liver microsomal enzyme inducing and inhibiting drugs on insulin mediated glucose metabolism in man.

Authors:  J T Lahtela; B Gachalyi; S Eksymä; A Hämäläinen; E A Sotaniemi
Journal:  Br J Clin Pharmacol       Date:  1986-01       Impact factor: 4.335

Review 5.  Pharmacokinetic-pharmacodynamic relationships of oral hypoglycaemic agents. An update.

Authors:  P Marchetti; R Navalesi
Journal:  Clin Pharmacokinet       Date:  1989-02       Impact factor: 6.447

6.  Association of non-alcoholic fatty liver disease with cardiovascular disease and subclinical atherosclerosis.

Authors:  Rahul Sao; Wilbert S Aronow
Journal:  Arch Med Sci       Date:  2017-07-05       Impact factor: 3.318

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.